Journal
PEDIATRIC ALLERGY AND IMMUNOLOGY
Volume 32, Issue 8, Pages 1824-1832Publisher
WILEY
DOI: 10.1111/pai.13574
Keywords
allergy; asthma; CCL18; chemokine; CXCL10; CXCL11; sensitization
Categories
Funding
- MRC [MR/L012693/1, MR/K002449/2, MR/S025340/1]
- Manchester Biomedical Research Centre (BRC)
- Swedish Research Council [2016-01698]
- Swedish Heart-Lung Foundation [20140321]
- Cancer and Allergy Foundation
- Foundation Samariten
- Ellen, Walter and Lennart Hesselman foundation
- Swedish Research Council [2016-01698] Funding Source: Swedish Research Council
- MRC [MR/L012693/1, MR/S025340/1] Funding Source: UKRI
Ask authors/readers for more resources
Studies found that in children with asthma and/or allergic sensitization, elevated CCL18 levels at ages 1 and/or 8 were associated with a higher risk of developing asthma from early school age to adolescence. Similarly, chemokines CXCL10 and CXCL11 were also linked to the development of both allergic sensitization and asthma, with differential temporal effects present.
Background Chemokines are important mediators in immune cell recruitment, contributing to allergy development. However, extensive studies of chemokines in the circulation in relation to the presence and development of allergic diseases remain scarce. Our aim was to investigate associations of circulating allergy-related chemokines with the development of asthma and sensitization cross-sectionally and longitudinally in a population-based cohort. Methods The chemokines CCL17, CCL22, CXCL10, CXCL11 and CCL18 were measured in plasma samples from children in the Manchester Asthma and Allergy Study. Samples were available from cord blood at birth (n = 376), age 1 (n = 195) and age 8 (n = 334). Cross-sectional and longitudinal association analyses were performed in relation to asthma and allergic sensitization, as well as allergic phenotype clusters previously derived using machine learning in the same study population. Results In children with asthma and/or allergic sensitization, CCL18 levels were consistently elevated at 1 and/or 8 years of ages. In a longitudinal model including information on asthma from 4 time points (5, 8, 11 and 16 years of ages), we observed a significant association between increasing CCL18 levels at age 1 and a higher risk of asthma from early school age to adolescence (OR = 2.9, 95% CI 1.1-7.6, p = .028). We observed similar associations in longitudinal models for allergic sensitization. Asthma later in life was preceded by increased CXCL10 levels after birth and decreased CXCL11 levels at birth. Conclusion Elevated CCL18 levels throughout childhood precede the development of asthma and allergic sensitization. The Th1-associated chemokines CXCL10 and CXCL11 also associated with the development of both outcomes, with differential temporal effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available